Amneal Pharmaceuticals (AMRX) Research & Development (2017 - 2026)
Amneal Pharmaceuticals (AMRX) posted Research & Development of $68.37 million for Q3 2026, up 7.9% from $63.35 million a year earlier and up 75.2% from the prior quarter.
Amneal Pharmaceuticals (AMRX) Research & Development (2017 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Research & Development at Amneal Pharmaceuticals was $180.59 million, down 12.2% year-over-year; for FY2025, it came in at $186.18 million, down 2.4% from FY2024.
- Annual Research & Development shows a five-year compound annual growth rate of 0.7% (FY2020 to FY2025).
- In prior years, Amneal Pharmaceuticals' Research & Development was $190.71 million in FY2024 (+16.3%), $163.95 million in FY2023 (-16.2%), $195.69 million in FY2022 (-3.1%) and $201.85 million in FY2021 (+12.2%).
- The Q3 2026 figure stands as the highest quarterly Research & Development in data going back to Q2 2017.
- On a year-over-year basis, Research & Development increased in five of the last eight quarters, with growth averaging 0.7%.
- The strongest year-over-year quarter for Research & Development in the past five years was Q3 2024, with growth of 47.7%; the weakest was Q4 2025, with a decline of 35.8%.
- According to Business Quant data, Research & Development for the three prior quarters was $39.02 million (Q2 2026), $38.38 million (Q1 2026) and $34.82 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,305.71 Bn | 1,279.33 Bn | 20.46 Bn | 4.25 Bn |
| 2 | Johnson & Johnson | 694.23 Bn | 614.09 Bn | 17.30 Bn | 4.65 Bn |
| 3 | AbbVie | 528.96 Bn | 496.97 Bn | 13.12 Bn | 2.57 Bn |
| 4 | Merck | 365.92 Bn | 328.86 Bn | 13.19 Bn | 4.54 Bn |
| 5 | Novartis Ag | 314.95 Bn | 288.19 Bn | - | - |
| 6 | Astrazeneca | 289.15 Bn | 262.67 Bn | 13.26 Bn | 3.89 Bn |
| 7 | Amgen | 254.11 Bn | 205.76 Bn | 7.58 Bn | 2.11 Bn |
| 8 | Gilead Sciences | 211.85 Bn | 186.96 Bn | 6.73 Bn | 1.61 Bn |
| 9 | Pfizer | 165.73 Bn | 113.09 Bn | 12.56 Bn | 3.02 Bn |
| 10 | Amneal Pharmaceuticals | 7.21 Bn | 6.44 Bn | 334.12 Mn | 68.37 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 68.37 Mn |
| Jun 30, 2026 | 39.02 Mn |
| Mar 31, 2026 | 38.38 Mn |
| Dec 31, 2025 | 34.82 Mn |
| Sep 30, 2025 | 63.35 Mn |
| Jun 30, 2025 | 47.96 Mn |
| Mar 31, 2025 | 40.04 Mn |
| Dec 31, 2024 | 54.27 Mn |
| Sep 30, 2024 | 61.10 Mn |
| Jun 30, 2024 | 36.05 Mn |
| Mar 31, 2024 | 39.30 Mn |
| Dec 31, 2023 | 46.09 Mn |
| Sep 30, 2023 | 41.38 Mn |
| Jun 30, 2023 | 37.80 Mn |
| Mar 31, 2023 | 38.69 Mn |
| Dec 31, 2022 | 41.91 Mn |
| Sep 30, 2022 | 50.24 Mn |
| Jun 30, 2022 | 50.75 Mn |
| Mar 31, 2022 | 52.80 Mn |
| Dec 31, 2021 | 51.87 Mn |
Amneal Pharmaceuticals Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=AMRX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "AMRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=AMRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();